Open Access
European Journal of Medicinal Chemistry, volume 225, pages 113788
Corrigendum to “Investigation of 3-sulfamoyl coumarins against cancer-related IX and XII isoforms of human carbonic anhydrase as well as cancer cells leads to the discovery of 2-oxo-2H-benzo[h]chromene-3-sulfonamide – A new caspase-activating proapoptotic agent” [J. Med. Chem. 222 (2021) 113589] (European Journal of Medicinal Chemistry (2021) 222, (S0223523421004384), (10.1016/j.ejmech.2021.113589))
Publication type: Journal Article
Publication date: 2021-12-01
Quartile SCImago
Q1
Quartile WOS
Q1
Impact factor: 6.7
ISSN: 02235234, 17683254
Organic Chemistry
Drug Discovery
General Medicine
Pharmacology
Metrics
Cite this
GOST |
RIS |
BibTex
Cite this
GOST
Copy
Darin D. et al. Corrigendum to “Investigation of 3-sulfamoyl coumarins against cancer-related IX and XII isoforms of human carbonic anhydrase as well as cancer cells leads to the discovery of 2-oxo-2H-benzo[h]chromene-3-sulfonamide – A new caspase-activating proapoptotic agent” [J. Med. Chem. 222 (2021) 113589] (European Journal of Medicinal Chemistry (2021) 222, (S0223523421004384), (10.1016/j.ejmech.2021.113589)) // European Journal of Medicinal Chemistry. 2021. Vol. 225. p. 113788.
GOST all authors (up to 50)
Copy
Darin D., Bunev A., Ostapenko G. I., Nocentini A., Supuran C. T., Krasavin M., Sharonova T., Sharoyko V., Kantin G., Kalinin S. Corrigendum to “Investigation of 3-sulfamoyl coumarins against cancer-related IX and XII isoforms of human carbonic anhydrase as well as cancer cells leads to the discovery of 2-oxo-2H-benzo[h]chromene-3-sulfonamide – A new caspase-activating proapoptotic agent” [J. Med. Chem. 222 (2021) 113589] (European Journal of Medicinal Chemistry (2021) 222, (S0223523421004384), (10.1016/j.ejmech.2021.113589)) // European Journal of Medicinal Chemistry. 2021. Vol. 225. p. 113788.
Cite this
RIS
Copy
TY - JOUR
DO - 10.1016/j.ejmech.2021.113788
UR - https://doi.org/10.1016%2Fj.ejmech.2021.113788
TI - Corrigendum to “Investigation of 3-sulfamoyl coumarins against cancer-related IX and XII isoforms of human carbonic anhydrase as well as cancer cells leads to the discovery of 2-oxo-2H-benzo[h]chromene-3-sulfonamide – A new caspase-activating proapoptotic agent” [J. Med. Chem. 222 (2021) 113589] (European Journal of Medicinal Chemistry (2021) 222, (S0223523421004384), (10.1016/j.ejmech.2021.113589))
T2 - European Journal of Medicinal Chemistry
AU - Darin, Dmitry
AU - Bunev, Alexander
AU - Ostapenko, Gennady I.
AU - Nocentini, Alessio
AU - Supuran, Claudiu T
AU - Krasavin, Mikhail
AU - Sharonova, Tatiana
AU - Sharoyko, Vladimir
AU - Kantin, Grigory
AU - Kalinin, Stanislav
PY - 2021
DA - 2021/12/01 00:00:00
PB - Elsevier
SP - 113788
VL - 225
SN - 0223-5234
SN - 1768-3254
ER -
Cite this
BibTex
Copy
@article{2021_Darin,
author = {Dmitry Darin and Alexander Bunev and Gennady I. Ostapenko and Alessio Nocentini and Claudiu T Supuran and Mikhail Krasavin and Tatiana Sharonova and Vladimir Sharoyko and Grigory Kantin and Stanislav Kalinin},
title = {Corrigendum to “Investigation of 3-sulfamoyl coumarins against cancer-related IX and XII isoforms of human carbonic anhydrase as well as cancer cells leads to the discovery of 2-oxo-2H-benzo[h]chromene-3-sulfonamide – A new caspase-activating proapoptotic agent” [J. Med. Chem. 222 (2021) 113589] (European Journal of Medicinal Chemistry (2021) 222, (S0223523421004384), (10.1016/j.ejmech.2021.113589))},
journal = {European Journal of Medicinal Chemistry},
year = {2021},
volume = {225},
publisher = {Elsevier},
month = {dec},
url = {https://doi.org/10.1016%2Fj.ejmech.2021.113788},
pages = {113788},
doi = {10.1016/j.ejmech.2021.113788}
}
Profiles